| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.3 | 2e-07 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.24 | 3e-07 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.17 | 6e-07 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.17 | 2e-05 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.22 | 3e-05 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.2 | 4e-05 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.22 | 0.0001 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.2 | 0.0001 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0005 |